As of June 1 2018 JAFRAL is a part of Bio-Pharm Competence Center for Biotechnology and Pharmaceuticals.
On 20th September 2017, WHO launched report about antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including tuberculosis. Report shows a
Because there have not been rigorous clinical trials of phages, they can be used only on patients for whom all other options have failed.
US regulators on Wednesday approved the first gene therapy against cancer - a treatment that uses a patient's own immune cells to fight leukemia - opening a new era in the fight against one of the
Scientists and physicians at University of California San Diego School of Medicine in collaboration with colleagues at the U.S. Navy Medical Research Center – Biological Defense Research Directorate
First gene therapy product could enter market in Q1 2018 The [...]